Sana Biotech Fights Investor Fraud Claims Over Trial Data
By Emilie Ruscoe · October 17, 2025, 5:06 PM EDT
Sana Biotechnology Inc. has asked a Seattle federal court to dismiss an investor suit over claims that it offered misleading statements regarding early clinical trials of a gene therapy, asserting that...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login